Cite
Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers.
MLA
Agrawal NGB, et al. “Dose Proportionality of Oral Etoricoxib, a Highly Selective Cyclooxygenase-2 Inhibitor, in Healthy Volunteers.” Journal of Clinical Pharmacology, vol. 41, no. 10, Oct. 2001, pp. 1106–10. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=106849456&authtype=sso&custid=ns315887.
APA
Agrawal NGB, Porras AG, Matthews CZ, Woolf EJ, Miller JL, Mukhopadhyay S, Neu DC, & Gottesdiener KM. (2001). Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers. Journal of Clinical Pharmacology, 41(10), 1106–1110.
Chicago
Agrawal NGB, Porras AG, Matthews CZ, Woolf EJ, Miller JL, Mukhopadhyay S, Neu DC, and Gottesdiener KM. 2001. “Dose Proportionality of Oral Etoricoxib, a Highly Selective Cyclooxygenase-2 Inhibitor, in Healthy Volunteers.” Journal of Clinical Pharmacology 41 (10): 1106–10. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=106849456&authtype=sso&custid=ns315887.